PRotecting cerebral injury and IMproving outcomEs with SGLT2 inhibitors in comatose Out-Of-Hospital Cardiac Arrest survivors – a Pilot Study (ACTRN12624001183572)

PRIME-OOHCA

This trial is Coming soon
Registration number ACTRN12624001183572
A double blinded randomised controlled pilot study comparing the outcomes of dapagliflozin vs placebo in patients with comatose cardiac arrest, with respect to hypoxic brain and ischaemia reperfusion injury

Program & service

This trial is being run with the Heart & Lung service, and as part of the Cardiology program.

Trial phase

Phase 2

Trial participation type

This trial has been designed for the Clinical Research of a Drug.

Principal investigator

Dr William Chan

Key inclusion data

Inclusion: Intubated out-of-hospital cardiac arrest with suspected ischaemic cause; Downtime <30 mins. Exclusion: Downtime >30 mins; History of type 1 diabetes mellitus; Cardiac arrest due to non-ischaemic causes.

More information

To find out more about this clinical trial, please review full details on the ANZCTR website.

View on ANZCTR

If you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.